Lumen Bioscience partnered with Google to use machine learning to advance the development of plant-based biologic drugs. The companies will harness the power of machine learning to increase the scalability of medicines based on spirulina, a type of blue-green algae. Lumen’s approach allows for the “rapid and low-cost mass production of new biologic drugs at
Patch News (August 11, 2021) A URI College of Pharmacy professor’s study on the potential use of chemicals commonly found in algal blooms to reduce neuroinflammation has been published in a journal of one of the largest scientific organizations.
